Association of Phosphodiesterase 4D Gene With Ischemic Stroke in a Pakistani Population
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (10) , 2275-2277
- https://doi.org/10.1161/01.str.0000182242.59466.ee
Abstract
Background and Objectives— Identification of STRK1 locus by the deCODE group followed by the discovery of phosphodiesterase 4D ( PDE4D ) gene in strong association with ischemic stroke patients has provided useful insights toward understanding the genetic etiology of the disease. In this study, we aimed at investigating the association between 3 polymorphisms of the PDE4D gene and ischemic stroke in the Pakistani population. Methods— Three polymorphisms in PDE4D gene were analyzed in 200 patients of ischemic stroke and 250 controls of Pakistani origin using polymerase chain reaction-restriction fragment length polymorphism method. Data were coded and entered in SPSS Windows (version 12.0). Odds ratios and 95% CIs were calculated using multivariate logistic regression analysis. Results— Marker SNP83(rs966221) was found significantly associated with ischemic stroke on univariate and multivariate analysis ( P Conclusion— The association of PDE4D variation with ischemic stroke extends to the Pakistani population and supports a role for phosphodiesterases in stroke pathogenesis.Keywords
This publication has 7 references indexed in Scilit:
- ALOX5AP Gene and the PDE4D Gene in a Central European Population of Stroke PatientsStroke, 2005
- Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteriesEuropean Journal of Pharmacology, 2004
- Genetics of Cerebrovascular DiseaseStroke, 2004
- The gene encoding phosphodiesterase 4D confers risk of ischemic strokeNature Genetics, 2003
- Sample Size Requirements for Association Studies of Gene-Gene InteractionAmerican Journal of Epidemiology, 2002
- Localization of a Susceptibility Gene for Common Forms of Stroke to 5q12American Journal of Human Genetics, 2002
- Section Review: Cardiovascular & Renal: Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseasesExpert Opinion on Investigational Drugs, 1995